Published in Arthritis Res Ther on October 13, 2011
Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice. Arthritis Rheumatol (2014) 0.97
Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography. Arthritis Res Ther (2012) 0.93
Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis. Arthritis Res Ther (2012) 0.92
T cells as key players for bone destruction in gouty arthritis? Arthritis Res Ther (2011) 0.83
The emerging role of biotechnological drugs in the treatment of gout. Biomed Res Int (2014) 0.79
Simplified Radiographic Damage Index for Affected Joints in Chronic Gouty Arthritis. J Korean Med Sci (2016) 0.77
Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition. Evid Based Complement Alternat Med (2017) 0.75
Rheumatology meets radiology in the hot soup of Gutta. Arthritis Res Ther (2012) 0.75
Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. Bone Rep (2015) 0.75
Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer. Oncotarget (2016) 0.75
Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages. Int J Mol Med (2017) 0.75
Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase. Mediators Inflamm (2015) 0.75
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Bone resorption by osteoclasts. Science (2000) 11.68
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol (2007) 5.86
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Pathogenesis of gout. Ann Intern Med (2005) 4.50
Gout. Lancet (2009) 4.33
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum (2000) 3.51
RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol (2001) 3.27
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest (2006) 3.21
Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest (2003) 3.14
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol (1998) 2.68
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum (2000) 2.61
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun (2000) 2.14
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol (1999) 1.96
Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum (2001) 1.85
Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest (1991) 1.75
Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum (2006) 1.73
MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood (2006) 1.60
Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum (2010) 1.52
Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol (2009) 1.39
Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum (2008) 1.36
The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis (2010) 1.34
Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology (Oxford) (1999) 1.30
Human osteoclasts derive from CD14-positive monocytes. Br J Haematol (1999) 1.30
Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis (1985) 1.30
Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum (1989) 1.28
Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) (2007) 1.23
Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood (2010) 1.23
Monosodium urate crystals in inflammation and immunity. Immunol Rev (2010) 1.20
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol (2007) 1.16
Continuous recruitment, co-expression of tumour necrosis factor-alpha and matrix metalloproteinases, and apoptosis of macrophages in gout tophi. Virchows Arch (2000) 1.16
Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum (2010) 1.08
Gout: new insights into an old disease. J Clin Invest (2006) 1.07
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum (2009) 1.07
The modern management of gout. Rheumatology (Oxford) (2009) 1.04
Pathology of the synovial membrane in gout. Light and electron microscopic studies. Interpretation of crystals in electron micrographs. Arthritis Rheum (1976) 1.03
Development of the gout tophus. An hypothesis. Am J Clin Pathol (1989) 1.02
Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum (1984) 1.02
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol (2004) 1.01
Uric acid directly promotes human T-cell activation. Am J Med Sci (2009) 0.99
Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res (2001) 0.88
Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules. Rheumatol Int (1987) 0.85
Hydroxyapatite and urate crystal induced cytokine release by macrophages. Ann Rheum Dis (1989) 0.82
The preosteoclast and its cytodifferentiation into the osteoclast: ultrastructural and histochemical studies of rat fetal parietal bone. Arch Histol Jpn (1983) 0.81
Osteoclastic bone resorption in rheumatoid arthritis and the acute-phase response. Rheumatology (Oxford) (2003) 0.80
v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med (2006) 3.78
Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol (2006) 3.18
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood (2005) 2.95
Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood (2007) 2.65
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation (2005) 2.44
NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol (2007) 2.25
A comparative study of meniscectomy and nonoperative treatment for degenerative horizontal tears of the medial meniscus. Am J Sports Med (2013) 1.89
Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol (2002) 1.82
Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol (2003) 1.79
Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem (2005) 1.62
MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood (2006) 1.60
The blue-light receptor YtvA acts in the environmental stress signaling pathway of Bacillus subtilis. J Bacteriol (2006) 1.55
Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population. J Rheumatol (2013) 1.44
Development of antisynthetase syndrome in a patient with rheumatoid arthritis. Rheumatol Int (2009) 1.43
Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood (2005) 1.38
The mechanism of osteoclast differentiation induced by IL-1. J Immunol (2009) 1.33
Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep (2005) 1.30
The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem (2008) 1.29
The PrpC serine-threonine phosphatase and PrkC kinase have opposing physiological roles in stationary-phase Bacillus subtilis cells. J Bacteriol (2002) 1.23
Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade. J Immunol (2011) 1.20
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol (2007) 1.16
Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest (2009) 1.15
Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem (2003) 1.14
BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem (2011) 1.10
Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. Circ J (2010) 1.09
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum (2009) 1.07
Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Circulation (2011) 1.06
Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett (2009) 1.05
The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis (2013) 1.03
Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance. Nucleic Acids Res (2010) 1.02
Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin Arthritis Rheum (2011) 1.02
Comparisons of kinematics and range of motion in high-flexion total knee arthroplasty: cruciate retaining vs. substituting designs. Knee Surg Sports Traumatol Arthrosc (2011) 1.02
Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. Rheumatology (Oxford) (2011) 1.01
Histone methyltransferase PRDM8 regulates mouse testis steroidogenesis. Biochem Biophys Res Commun (2009) 1.01
Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. Proc Natl Acad Sci U S A (2010) 1.00
Technique and early experience with posterior arthroscopic subtalar arthrodesis. Foot Ankle Int (2007) 0.98
Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology (2007) 0.98
Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation. J Biol Chem (2006) 0.98
Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection. Infect Immun (2012) 0.98
Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol (2002) 0.98
Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis. Joint Bone Spine (2012) 0.98
Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci (2002) 0.96
Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum (2002) 0.96
The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine. Am J Chin Med (2002) 0.95
Comparison of early versus delayed weightbearing outcomes after microfracture for small to midsized osteochondral lesions of the talus. Am J Sports Med (2012) 0.95
Molecular cloning and expression of human keratinocyte proline-rich protein (hKPRP), an epidermal marker isolated from calcium-induced differentiating keratinocytes. J Invest Dermatol (2005) 0.95
Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation. J Biol Chem (2011) 0.94
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum (2008) 0.94
MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Cell Signal (2010) 0.94
Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas. J Korean Med Sci (2002) 0.94
The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res (2003) 0.93
Symbiotic adaptation of bacteria in the gut of Reticulitermes speratus: low endo-beta-1,4-glucanase activity. Biochem Biophys Res Commun (2010) 0.92
Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation. J Biol Chem (2009) 0.92
Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J Biol Chem (2009) 0.91
Hypertonic stress increased extracellular ATP levels and the expression of stress-responsive genes in Arabidopsis thaliana seedlings. Biosci Biotechnol Biochem (2009) 0.91
First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea. Chonnam Med J (2011) 0.91
Association of FOXJ1 polymorphisms with systemic lupus erythematosus and rheumatoid arthritis in Korean population. Exp Mol Med (2007) 0.91
MicroRNA-26a regulates RANKL-induced osteoclast formation. Mol Cells (2014) 0.90
Evaluating the Korean version of the Multidimensional Health Assessment Questionnaire in patients with rheumatoid arthritis. Clin Rheumatol (2005) 0.90
Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor. J Immunol (2007) 0.90
Total ankle arthroplasty outcome comparison for post-traumatic and primary osteoarthritis. Foot Ankle Int (2010) 0.90
Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int (2008) 0.90
MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis. Arthritis Res Ther (2014) 0.89
Early growth response 2 negatively modulates osteoclast differentiation through upregulation of Id helix-loop-helix proteins. Bone (2012) 0.89
Progression of osteoarthritis after double- and single-bundle anterior cruciate ligament reconstruction. Am J Sports Med (2013) 0.89
Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway. Toxicol Lett (2005) 0.89
Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int (2008) 0.89
Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction. J Immunol (2010) 0.89
Beta-catenin modulates the level and transcriptional activity of Notch1/NICD through its direct interaction. Biochim Biophys Acta (2008) 0.88
Isolation of Lawsonia intracellularis in Korea and reproduction of proliferative enteropathy in pigs and hamsters. J Vet Med Sci (2006) 0.88
RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation. Biochem J (2011) 0.88
Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. Arthritis Care Res (Hoboken) (2015) 0.88